Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Spain

European Research Council grant · Running

GenomeDia GenomeDia: a personalized medicine tool for diabetes

Coordinator
Fundacio Centre De Regulacio Genomica, Spain
Runs
1 August 2024 to 31 January 2026
Status
Running
EU funding
€150k
Total cost
—
Partners
1 organisations in 1 countries
Type
European Research Council grant
Grant agreement
101157669

What the project is doing

In the project's own words, from its summary on CORDIS.

Diabetes Mellitus affects nearly 600 million people worldwide. It is a major cause of premature death, blindness, end stage kidney disease, and limb amputation. However, it is not a single disease. Most patients are catalogued as type 2 diabetes, which is itself highly heterogeneous, while others have autoimmune type 1 diabetes. Genetic testing is currently able to define the precise cause of diabetes in a small group of young patients, although the categorization of diabetes subtypes is in most cases largely based on clinical judgement, rather than on specific tests.

It is known, however, that the classification of diabetes subtypes has major implications for treatment. The emergence of whole genome sequencing in clinical practice provides new opportunities for classification of diabetes subtypes, but also entails major challenges such as the interpretation of non protein-coding variants. The recently funded ERC project DecodeDiabetes analyzed sequences from nearly 1500 young patients who had typical features of genetic forms of diabetes, but negative genetic tests in specialized genetic diagnostic laboratories.

This study revealed different groups of genetic variants that cause diabetes in young patients with diabetes. It also developed approaches that leverage regulatory genomic knowledge to define noncoding genetic defects underlying human disease. The current proposal aims to compile new findings with existing knowledge, and to build a genetic interpretation solution to subcategorize young patients with diabetes. It will then validate this tool in patient cohorts.

This proposal can thus translate fundamental knowledge derived from the ERC-funded Decode Diabetes project into applications whose valorization can bridge the gap to market and provide added value for society.

Topics

Who is involved

OrganisationCityCountryRole
Fundacio Centre De Regulacio GenomicaBarcelonaSpainCoordinator

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI